Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Rheumatoid Arthritis
Related studies linked through entity extraction aliases.
A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
- Status
- COMPLETED
- Phase
- PHASE3
A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
- Status
- COMPLETED
- Phase
- PHASE4
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis
- Status
- WITHDRAWN
- Phase
- PHASE2
Remission and Joint Damage Progression in Early Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations
- Status
- COMPLETED
- Phase
- N/A
Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire
- Status
- COMPLETED
- Phase
- PHASE4
Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE3
Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
- Status
- COMPLETED
- Phase
- N/A
Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
- Status
- COMPLETED
- Phase
- N/A
Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)
- Status
- COMPLETED
- Phase
- PHASE4
Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE4
Treatment for Subjects With Active Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Pulsed Magnetic Pads on Rheumatoid Arthritis Symptoms in Postmenopausal Women
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3